Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Home - Clinical Trials Arena
WEBAlio starts trial to expand label for remote monitoring device. The CAVA study is expected to validate the use of SmartPatch technology. More themes. Artificial Intelligence. Cloud. Corporate Governance. Cybersecurity. Environmental Sustainability. Internet of Things.
Alzheimer's trials: How does donanemab compare to lecanemab?
WEBJan 13, 2023 · Lecanemab is the only AD drug to demonstrate a slowing of cognitive decline in a Phase III study, setting the benchmark for the field. The Phase III TRAILBLAZER-ALZ-2 trial of donanemab uses the iADRS scale, which was developed by Lilly. iADRS combines two established scales: the cognitive scale Alzheimer’s Disease …
Features - Clinical Trials Arena
WEBPipeline Moves: Phase III completion for Corcept’s relacorilant. Clinical Trials Arena Team. Features.
EU Clinical Trial Regulation: What You Need to Know
WEBMay 20, 2021 · The European Medicines Agency (EMA) has announced that its long-delayed clinical trial EU Portal and Database, one of the main features of the Clinical Trial Regulation 536/2014 and the key component of the Clinical Trial Information System (CTIS), is now finally fully functional and fit for purpose with 31 January 2022 pencilled in as the go-live date.
FDA clears Revive Therapeutics’ Covid-19 trial of Bucillamine
WEBAug 3, 2020 · Bucillamine is indicated to treat rheumatoid arthritis in Japan and South Korea. In Covid-19 patients, the drug is expected to increase glutathione activity and other anti-inflammatory activity in order to mitigate the complications of the disease in the lungs. The multi-centre, randomised, double-blind, placebo-controlled Phase III trial will ...
Phase 0 clinical trials: what you need to know
WEBJul 21, 2022 · Clinical Trials Arena breaks down the two most common types of Phase 0 trials, including window of opportunity trials in neuro-oncology. William Newton July 21, 2022. When the FDA introduced Phase 0 trials in 2006, the goal was to learn more about new drugs without exposing subjects to their full, potentially toxic, effects.
Healthy patients, healthy planet: tackling the carbon footprint of ...
WEBJul 27, 2021 · A study in 2009 of 12 pragmatic randomised trials showed that the average carbon emission of the trials was about the same as that of nine people in the UK in one year. We then went on to calculate the carbon footprint if we brought together all of the trials on clinicaltrials.gov where there were 350,000 national and international trials.
Insights - Clinical Trials Arena
WEBQ2 2024 update: social responsibility related hiring actvity in the pharma industry. The global pharmaceutical industry experienced a 22% rise in new job postings related to social responsibility in Q2 2024 compared…. Jobs.
Tesofensine Anti-Obesity Medication - Clinical Trials Arena
WEBDec 14, 2008 · Dose-dependent adverse gastrointestinal effects were observed with tesofensine in the clinical trials in addition to increases in blood pressure and heart. However, at the anticipated therapeutic dose of 0.5mg, discontinuations for adverse effects with tesofensine were similar to placebo (8%). In …